AlivaMab Biologics
PrivateLast Round
Seed
May 1, 2018
Momentum
Top 1%
of companies Caplight tracks
Company Overview
AlivaMab Biologics is a drug discovery company that provides fully integrated solutions for biologics drug discovery through its platform of innovative capability modules.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlivaMab Biologics Comparables
Compare AlivaMab Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbTherx, Inc. | 86% | |
| Alloy Therapeutics | 80% | |
| Ablexis | 80% | |
AlivaMab Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2018 |
Key People
Founding team and executive leadership
AlivaMab Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 24, 73% of headcount.
- Jul 5, 2025
Monthly visitors increased 42% MoM.
AlivaMab Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AlivaMab Biologics's valuation, stock price, and market status.